References
- Sato T, Fuse A, Eguchi M, Hayashi Y, Ryo R, Adachi M, Kishimoto Y, Teramura M, Mizoguchi H, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajima H. Establishment of a human leukemic cell line(CMK) with megakaryocyte characteristics from a Down's syndrome patient with acute megakaryoblastic leukemia. Br J Haematol 1989; 72: 184–190
- Read M S, Reddick R L, Bode A P, Bellinger D A, Nichols T C, Taylor K T, Smith S V, McMahon D K, Griggs T R, Brinkhous KM. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995; 92: 397–401
- Chao F C, Kim B K, Houranieh A M, Liang F H, Konrad M W, Swisher S N, Tullis JL. Infusible platelet membrane micro vesicles: a potential transfusion substitute for platelets. Transfusion 1996; 36: 536–542
- Coller B S, Springer K T, Beer J H, Mohandas N, Scudder L E, Norton K J, West SM. Thromboerythrocyte. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusion. J Clin Invest 1992; 89: 546–555
- Rybak M, Renzulli LA. A liposome based platelet substitute, the Plateletsome, with hemostatic efficacy. Biomat Art Cells&Immob Biotech 1993; 21: 101–118
- de Sauvage F J, Hass P E, Spencer S D, Malloy B E, Gurney A L, Spencer S A, Darbonne W C, Henzel W J, Wong S C, Kuang W J, Oles K J, Hultgren B, Jr, Solberg L A, Goeddel D V, Eaton DL. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533–538
- Lok S, Kaushansky K, Holly R D, Kuijper J L, Lofton-Day C E, Oort P J, Grant F J, Heipel M D, Burkhead S K, Kramer J M, Anne Bell L, Sprecher C A, Blumberg H, Johenson R, Prunkard D, Ching A FT, Mathewes S L, Bailey M C, Forstrom J W, Buddie M M, Osborn S G, Evans S J, Sheppard P O, Presnell S R, O'Hara P, Hagen F S, Roth G J, Foster DC. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994; 369: 565–567
- Cattral M S, Krajden M, Wanless I R, Rezig M, Cameron R, Greig P D, Chung S W, Levy GA. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 1996; 61: 1483–1488
- Majumdar A, Kerby S, Stenberg P E, Mullikin B, Beckstead J H, Cooney D A, Seidman MM. IL-3 and ribavirin induce high level expression of megakaryocytic markers and messages during long-term treatment of a megakaryocytic leukemia cell line. J Cell Physiol 1994; 160: 29–39
- Higuchi T, Koike K, Sawai N, Koike T. Proliferative and differentiative potential of thrombopoietin-responsive precursors: expression of megakaryocytic and erythroid lineages. Exp Hematol 1997; 25: 463–470
- Ulich T R, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan W T, Hunt P. Megakaryocyte growth and development factor ameliorates Carboplatin-induced thrombocytopenia in mice. Blood 1995; 86: 971–976
- Farese A M, Hunt P, Grab L B, MacVittie TJ. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stumulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996; 97: 2145–2151
- Rollwagen F M, Gafhey W CM, Pacheco N D, Davis T A, Hickey T M, Nielsen T B, Rudolph AS. Multiple responses to administration of liposome-encapsulated hemoglobin(LEH): Effects on hematopoiesis and serum IL-6 levels. Exp Hematol 1996; 24: 429–436